ArticleCurrent issues in molecular biology2026
Cross-Scale Convergence in Epigenetic Gene Regulation: A Perspective on Functional Enrichment Analytics for Cancer.
Article in Current issues in molecular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Epigenetic regulation of gene expression is studied at three physical scales: micro: DNA sequence-level methylation/demethylation; meso: nucleosome occupancy and remodeling; and macro: chromosomal domain silencing by Polycomb complexes, heterochromatin, and topologically associating domain (TAD) boundaries. The challenge to fully understand epigenetic gene regulation patterns is that these scales are not independent. Their influence overlaps and they share a recurring architectural theme across scales of a targeted molecular pattern followed by cooperative, feedback-driven, spatially bounded spreading. We argue here that disruption of this shared architecture at any one scale is independently sufficient to tip a bistable silencing domain into an oncogenic state. This paper discusses how such a cross-scale architectural rule set has concrete implications (yet underexploited) for computational cancer epigenomics, e.g., functional enrichment analyses generally focus on epigenetic features at one scale as an independent line of evidence, ignoring corroborating signals that could be reinforced by underlying hierarchical levels. This paper outlines options for functional enrichment statistics that combine multiple corroborating molecular features within a scale and corroborating evidence across scales into composite confidence scores calibrated against an empirical null that preserves correlations between assays. We propose benchmarking this approach against conventional single-feature enrichment in matched multi-omic cancer datasets as a direct test of the model.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.